Literature DB >> 15897480

Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects.

Tanja C M Adam1, Johan Jocken, Margriet S Westerterp-Plantenga.   

Abstract

OBJECTIVE: Postprandial glucagon-like peptide 1 (GLP-1) release seems to be attenuated in obese subjects. Results on whether weight loss improves GLP-1 release are contradictory. The aim of this study was to further investigate the effect of weight loss on basal and postprandial GLP-1 release in overweight/obese subjects. RESEARCH METHODS AND PROCEDURES: Thirty-two overweight/obese subjects participated in a repeated measurement design before (BMI, 30.3 +/- 2.8 kg/m2; waist circumference, 92.6 +/- 7.8 cm; hip circumference, 111.1 +/- 7.4 cm) and after a weight loss period of 6 weeks (BMI, 28.2 +/- 2.7 kg/m2; waist circumference, 85.5 +/- 8.5 cm; hip circumference, 102.1 +/- 9.2 cm). During weight loss, subjects received a very-low-calorie diet (Optifast) to replace three meals per day. Subjects came to the laboratory fasted, and after a baseline blood sample, received a standard breakfast (1.9 MJ). Postprandially, blood samples were taken every one-half hour relative to intake for 120 minutes to determine GLP-1, insulin, glucose, and free fatty acids from plasma. Appetite ratings were obtained with visual analog scales.
RESULTS: After weight loss, postprandial GLP-1 concentrations at 30 and 60 minutes were significantly lower than before weight loss (p < 0.05). Glucose concentrations were also lower, and free fatty acids were higher compared with before weight loss. Ratings of satiety were increased, and hunger scores were decreased after weight loss (p < 0.05). DISCUSSION: In overweight/obese subjects, GLP-1 concentrations after weight loss were decreased compared with before weight loss, and nutrient-related stimulation was abolished. This might be a response to a proceeding negative energy balance. Satiety and GLP-1 seem to be unrelated in the long term.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897480     DOI: 10.1038/oby.2005.80

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  27 in total

1.  Nutrient-specific feeding and endocrine effects of jejunal infusions in obese animals.

Authors:  Megan J Dailey; Alexander A Moghadam; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-22       Impact factor: 3.619

2.  Exercise reduces appetite and traffics excess nutrients away from energetically efficient pathways of lipid deposition during the early stages of weight regain.

Authors:  Amy J Steig; Matthew R Jackman; Erin D Giles; Janine A Higgins; Ginger C Johnson; Chad Mahan; Edward L Melanson; Holly R Wyatt; Robert H Eckel; James O Hill; Paul S MacLean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-29       Impact factor: 3.619

Review 3.  The gut sensor as regulator of body weight.

Authors:  Thomas Reinehr; Christian L Roth
Journal:  Endocrine       Date:  2014-12-30       Impact factor: 3.633

Review 4.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

Review 5.  Biology's response to dieting: the impetus for weight regain.

Authors:  Paul S Maclean; Audrey Bergouignan; Marc-Andre Cornier; Matthew R Jackman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

6.  The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study.

Authors:  George Thom; Stephan U Dombrowski; Naomi Brosnahan; Yasmin Y Algindan; M Rosario Lopez-Gonzalez; Giles Roditi; Michael E J Lean; Dalia Malkova
Journal:  Eur J Clin Nutr       Date:  2020-02-04       Impact factor: 4.016

7.  No effect of 24 h severe energy restriction on appetite regulation and ad libitum energy intake in overweight and obese males.

Authors:  D J Clayton; M Creese; N Skidmore; D J Stensel; L J James
Journal:  Int J Obes (Lond)       Date:  2016-06-24       Impact factor: 5.095

8.  Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.

Authors:  Sarah Evans; Zehra Pamuklar; Jonathan Rosko; Patrick Mahaney; Ning Jiang; Chan Park; Alfonso Torquati
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

9.  Postprandial plasma incretin hormones in exercise-trained versus untrained subjects.

Authors:  Edward P Weiss; Nathaniel K Royer; Jonathan S Fisher; John O Holloszy; Luigi Fontana
Journal:  Med Sci Sports Exerc       Date:  2014-06       Impact factor: 5.411

10.  Role of rs6923761 gene variant in glucagon-like peptide 1 receptor in basal GLP-1 levels, cardiovascular risk factor and serum adipokine levels in naïve type 2 diabetic patients.

Authors:  D A de Luis; R Aller; O Izaola; R Bachiller
Journal:  J Endocrinol Invest       Date:  2014-09-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.